, Tracking Stock Market Picks
Enter Symbol:
Abaxis, Inc. (ABAX) [hlAlert]

down 19.52 %

Abaxis, Inc. (ABAX) downgraded to Underperform by BofA/Merrill

Posted on: Friday,  Feb 28, 2014  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Underperform Abaxis, Inc. (NASDAQ: ABAX) on 02/28/2014, when the stock price was $37.95. Since
then, Abaxis, Inc. has gained 24.27% as of 11/12/2015's recent price of $47.16.
If you would have followed this BofA/Merrill's recommendation on ABAX, you would have lost 19.52% of your investment in 622 days.

Abaxis, Inc. develops, manufactures and markets portable blood analysis systems for use in any patient-care setting to provide clinicians with rapid blood constituent measurements. The Company's primary product is a system consisting of a compact 6.9 kilogram analyzer and a series of single-use plastic discs called reagent discs containing all the chemicals required to perform a panel of up to 12 tests. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma using either venous or fingerstick samples.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/28/2014 8:25 AM Sell
as of 10/17/2014
1 Week down  -1.16 %
1 Month up  8.80 %
3 Months down  -14.42 %
1 YTD down  -26.03 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/4/2013 8:25 AM Hold
2/25/2013 8:25 AM Sell

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy